We are live on
!
Find out more
Anika Therapeutics
ANIK
ANIK
117 hedge funds and large institutions have $311M invested in Anika Therapeutics in 2023 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 42 increasing their positions, 40 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
28% more capital invested
Capital invested by funds: $242M → $311M (+$69M)
10% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 20
5.12% more ownership
Funds ownership: 88.7% → 93.82% (+5.1%)
5% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 40
1% more funds holding
Funds holding: 116 → 117 (+1)
23% less call options, than puts
Call options by funds: $61K | Put options by funds: $79K
Holders
117
Holders Change
+1
Holders Change %
+0.86%
% of All Funds
1.71%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
22
Increased
42
Reduced
40
Closed
20
Calls
$61K
Puts
$79K
Net Calls
-$18K
Net Calls Change
+$17K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$15M |
| 2 |
CM
Capital Management
Glen Allen,
Virginia
|
+$5.61M |
| 3 |
AFA
Alta Fundamental Advisers
New York
|
+$3.98M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$2.66M |
| 5 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$2.41M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$5.67M |
| 2 |
Millennium Management
New York
|
-$5.11M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.51M |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$2.24M |
| 5 |
TI
Trigran Investments
Northbrook,
Illinois
|
-$1.61M |
